UnitedHealth Group Incorporated (NYSE:UNH) had its price target raised by research analysts at Bank of America Corporation from $210.00 to $214.00 in a research report issued on Friday, July 14th. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Bank of America Corporation’s price target would suggest a potential upside of 10.87% from the company’s current price.
Other equities analysts have also recently issued reports about the company. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price for the company in a report on Wednesday, April 5th. Deutsche Bank AG started coverage on UnitedHealth Group in a report on Wednesday, April 5th. They set a “buy” rating and a $183.00 target price for the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a report on Tuesday, March 21st. Stifel Nicolaus restated a “buy” rating and set a $185.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 19th. Finally, Mizuho raised their target price on UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, April 18th. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $202.20.
UnitedHealth Group (NYSE:UNH) opened at 193.02 on Friday. The firm’s 50-day moving average is $189.36 and its 200 day moving average is $174.75. The stock has a market capitalization of $186.62 billion, a price-to-earnings ratio of 23.19 and a beta of 0.64. UnitedHealth Group has a 1-year low of $132.39 and a 1-year high of $196.04.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company’s revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.96 EPS. Equities analysts anticipate that UnitedHealth Group will post $9.87 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) PT Raised to $214.00 at Bank of America Corporation” was published by BNB Daily and is the sole property of of BNB Daily. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.baseball-news-blog.com/2017/08/13/unitedhealth-group-incorporated-unh-pt-raised-to-214-00-at-bank-of-america-corporation-updated-updated-updated.html.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the transaction, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,540 shares of company stock worth $2,873,320. 0.89% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Dodge & Cox bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $1,658,560,000. Norges Bank bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $1,530,177,000. Harbour Capital Advisors LLC increased its position in shares of UnitedHealth Group by 18,383.4% in the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after buying an additional 2,503,090 shares during the period. Viking Global Investors LP bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $354,206,000. Finally, Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares during the period. Institutional investors own 86.37% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com’s FREE daily email newsletter.